Loss of FHIT expression in gastric carcinoma

Cancer Research

Volumn 58, Issue 20, 1998, Pages 4708-4714

  Baffa, Raffaele ^a   Veronese, Maria Luisa ^a   Santoro, Robert ^b   Mandes, Bernadette ^a   Palazzo, Juan P ^a   Rugge, Massimo ^c   Santoro, Eugenio ^b   Croce, Carlo M ^a   Huebner, Kay ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CHROMOSOME 3; GENE DELETION; GENE LOCUS; GENE REARRANGEMENT; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE;

ACID ANHYDRIDE HYDROLASES; BLOTTING, SOUTHERN; CHROMOSOMES, HUMAN, PAIR 3; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PROTEINS; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0032532617     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Wingo, P., Tong, T., and Bolden, S. Cancer statistics, 1995. CA Cancer J. Clin., 45: 8-30, 1995.
2. Whelan, S. L., Parkin, D. M., and Masuyer, E. (eds.). Trends in Cancer Incidence, and Mortality. IARC Scientific Publ. No. 102. Lyon, France: IARC, 1993.
3. Boring, C. C., Squires, T. S., Tong, T., and Montgomery, S. Cancer statistics. CA Cancer J. Clin., 44: 7-26, 1994.
4. Rugge, M., Cassaro, M., Leandro, G., Baffa, R., Avellini, C., Bufo, P., Stracca, V., Battaglia, G., Fabiano, A., Guerini, A., and Di Mario, F. Helicobacter pylori in promotion of gastric carcinogenesis. Dig. Dis. Sci., 41: 950-955, 1996.
5. Kneller, R. W., You, W. C., Chang, Y. S., Liu, W. D., Zhang, L., Zhao, L., Xu, G. W., Fraumeni, J. F., Jr., and Blot, W. J. Cigarette smoking and other risk factors for progression of precancerous stomach lesions. J. Natl. Cancer Inst., 84: 1261-1266, 1992.
6. You, W. C., Zhang, L., Yang, C. S., Chang, Y. S., Issaq, H., Fox, S. D., Utermanhlen, W. E., Zhao, L., Keefer, L., Liu, W. D., Chow, W. H., Ma, J. L., Kneller, L., Ho, M. Y. K., Fraumeni, J. F., Jr., Xu, G. W., and Blot, W. J. Nitrite, N-nitroso compounds, and other analytes in physiological fluids in relation to precancerous gastric lesions. Cancer Epidemiol. Biomark. Prev., 5: 47-52, 1996.
7. Baik, S. C., Youn, H. S., Chung, M. H., Lee, W. K., Cho, M. J., Ko, G. H., Park, C. K., Kasai, H., and Rhee, K. H. Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Cancer Res., 56: 1279-1282, 1996.
8. Lauren, P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol. Microbiol. Scand., 64: 31-49, 1965.
9. Correa, P. Helicobacter pylori and gastric carcinogenesis. Am. J. Surg. Pathol., 19 (Suppl. 1): S37-S43, 1995.
10. Correa, P., and Shiao, Y. H. Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res., 54 (Suppl.): 1941s-1943s, 1994.
11. Tahara, E., Semba, S., and Tahara, H. Molecular biological observations in gastric cancer. Semin. Oncol., 23: 307-315, 1996.
12. Sano, T., Tsujino, T., Yoshida, K., Nakayama, H., Haruma, K., Ito, H., Nakamura, Y., Kajiyama, G., and Tahara, E. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas. Cancer Res., 51: 2926-2931, 1991.
13. Schneider, B. G., Pulitzer, D. R., Brown, R. D., Prihoda, T. J., Bostwick, T. J., Bostwick, D. G., Saldivar, V., Rodriguez-Martinez, H. A., Gutierrez-Diaz, M. E., and O'Connell, P. Allelic imbalance in gastric cancer: an affected site on chromosome arm 3p. Genes Chromosomes Cancer, 13: 263-271, 1995.
14. Rao, P. H., Mathew, S., Kelsen, D. P., and Chaganti, R. S. Cytogenetics of gastric and esophageal adenocarcinomas. 3q deletion as a possible primary chromosomal change. Cancer Genet. Cytogenet., 81: 139-143, 1995.
15. Rhyu, M. G., Park, W. S., Jung, Y. J., Choi, S. W., and Meltzer, S. J. Allelic deletions of DCC/APC and p53 are frequent late events in human gastric carcinogenesis. Gastroenterology, 106: 1584-1588, 1994.
16. Tamura, G., Ogasawara, S., Nishizuka, S., Sakata, K., Maesawa, C., Suzuki, Y., Terashima, M., Saito, K., and Satodate, R. Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach. Cancer Res., 56: 612-615, 1996.
17. Quiemado, L., Seruca, R., Costa-Perira, A., and Castedo, S. Identification of two distinct regions of deletion at 6q in gastric carcinoma. Genes Chromosomes Cancer, 14: 28-34, 1995.
18. Baffa, R., Negrini, M., Mandes, B., Rugge, M., Ranzani, G. N., Hirohashi, S., and Croce, C. M. Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach. Cancer Res., 56: 268-272, 1996.
19. Motomura, K., Nishisho, I., Takai, S. I., Tateishi, H., Okazaki, M., Yamamoto, M., Miki, T., Honjo, T., and Mori, T. Loss of alleles at loci on chromosome 13 in human primary gastric cancers. Genomics, 2: 180-184, 1988.
20. Schmutte, C., Baffa, R., Veronese, L. M., Murakumo, Y., and Fishel, R. Human thymine-DNA glycosylase maps at chromosome 12q22-q24.1: a region of high loss of heterozygosity in gastric cancer. Cancer Res., 57: 3010-3015, 1997.
21. Kastury, K., Baffa, R., Druck, T., Ohta, M., Cotticelli, M. G., Inoue, H., Negrini, M., Rugge, M., Huang, D., Croce, C. M., Palazzo, J., and Huebner, K. Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRAB3B site identified by homozygous deletions in tumor cell lines. Cancer Res., 56: 978-983, 1996.
22. Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili, Z., Mori, M., McCue, P., Druck, T., Croce, C. M., and Huebner, K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 84: 587-597, 1996.
23. Sozzi, G., Veronese, M. L., Negrini, M., Baffa, R., Cotticelli, M. G., Inoue, H., Tornielli, S., Pilotti, S., De Gregorio, L., Pastorino, U., Pierotti, M., Ohta, M., Huebner K., and Croce, C. M. The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell, 85: 17-26, 1996.
24. Negrini, M., Monaco, C., Vorechovsky, L, Ohta, M., Druck, T., Baffa, R., Huebner, K., and Croce, C. M. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res., 56: 3171-3179, 1996.
25. Virgilio, L., Shuster, M., Gollin, S. M., Veronese, M. L., Ohta, M., Huebner, K., and Croce, C. M. FHIT gene alterations in head and neck squamous cell carcinomas. Proc. Natl. Acad. Sci. USA. 93: 9770-9775, 1996.
26. Tamura, G., Sakata, K., Nishizuka, S., Maesawa, C., Suzuki, Y., Iwaya, T., Terashima, M., Saito, K., and Satodate, R. Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines. Genes Chromosomes Cancer, 20: 98-102, 1997.
27. Hendricks, D. T., Taylor, R., Reed, M., and Birrer, M. J. FHIT gene expression in human ovarian, endometrial, and cervical cancer cell lines. Cancer Res., 57: 2112-2115, 1997.
28. Mao, L., Fan, Y. H., Lotan, R., and Hong, W. K. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Cancer Res., 56: 5128-5131, 1996.
29. 3-triphosphate hydrolase. Biochemistry, 35: 11529-11535, 1996.
30. Wilke, C. M., Hall, B. K., Hoge, A., Paradee, W., Smith, D. I., and Glover, T. W. FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum. Mol. Genet., 5: 187-195, 1996.
31. Rassool, F. V., Le Beau, M. M., Shen, M. L., Neilly, M. E., Espinosa, R., III, Ong, S. T., Boldog, F., Drabkin, H., McCarroll, R., and McKeithan, T. W. Direct cloning of DNA sequences from the common fragile site region at chromosome band 3p14.2. Genomics, 35: 109-117, 1996.
32. Druck, T., Hadaczek, P., Fu, T. B., Ohta, M., Siprashvili, Z., Baffa, R., Negrini, M., Kastury, K., Veronese, M. L., Rosen, D., Rothstein, J., McCue, P., Cotticelli, M. G., Inoue, H., Croce, C. M., and Huebner, K. Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res., 57: 504-512, 1997.
33. Siprashvili, Z., Sozzi, G., Barnes, L. D., McCue, P., Robinson, A. K., Eryomin, V., Sard, L., Tagliabue, E., Greco, A., Fusetti, L., Schwartz, G., Pierotti, M. A., Croce, C. M., and Huebner, K. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc. Natl. Acad. Sci. USA. 94: 13771-13776, 1997.
34. Gemma, A., Hagiwara, K., Ke, Y., Burke, L. M., Khan, M. A., Nagashima, M., Bennett, W. P., and Harris, C. C. FHIT mutations in human primary gastric cancer. Cancer Res., 57: 1435-1437, 1997.
35. Barranco, S. C., Townsend, C. M., Jr., Casartelli, C., Macik, B. G., Burger, N. L., Boerwinkle, W. R., and Gourley, W. K. Establishment and characterization of an in vitro system for human adenocarcinoma of the stomach. Cancer Res., 43: 1703-1709. 1983.
36. Sekiguchi, M., Sakakibara, K., and Fujii, G. Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn. J. Exp. Med., 48: 61-68, 1978.
37. Wang, K. H. Acta. Biol. Exp. Sin., 16: 257-262, 1983.
38. Park, J. G., Frucht, H., La Rocca, R. V., Bliss, D. P., Jr., Kurita, Y., Chen, T-R., Henslee, J. G., Trepel, J. B., Jensen, R. T., Johnson, B. E., Bang, Y-J., Kim, J-P., and Gazdar, A. F. Characteristics of cell lines established from gastric carcinoma. Cancer Res., 50: 2773-2780, 1990.
39. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, 1989.
40. Greenspan, D. L., Connolly, D. C, Wu, R., Lei, R. Y., Vogelstein, J. T., Kim, Y. T., Mok, J. E., Muñoz, N., Bosch, F. X., Shah, K., and Cho, K. R. Loss of FHIT expression in cervical carcinoma cell and primary tumors. Cancer Res., 57: 4692-4698, 1997.
41. Hadaczek, P., Siprashvili, Z., Markiewski, M., Druck, T., McCue, P. A., Domagala, W., Ohta, M., Huebner, K., and Lubinski, J. Absence or reduction of Fhit expression most clear cell renal carcinomas. Cancer Res., 58: 2946-2951, 1998.
42. Fong, K. M., Biesterveld, E. J., Virmani, A., Wistuba, I., Sekido, Y., Bader, S. A., Ahmadian, M., Ong, S. T., Rassool, F. V., Zimmerman, P. V., Ciaccone, G., Gazdar, A. F., and Minna, J. A. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res., 57: 2256-2267, 1997.
43. Becker, K. F., Atkinson, M. J., Reich, U., Becker, I., Nekarda, H., Siewert, J. R., and Hofler, H. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 54: 3845-3852, 1994.
44. Ranzani, G. N., Luinetti, O., Padovan, L. S., Calistri, D., Renault, B., Burrel, M., Amadori, D., Fiocca, R., and Solcia, E. p53 mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type. Cancer Epidemiol. Biomark. Prev., 4: 223-231, 1995.
45. Sozzi, G., Tornielli, S., Tagliabue, E., Sard, L., Pezzella, F., Pastorino, U., Minoletti, F., Pilotti, S., Ratcliffe, C., Veronese, M. L., Goldstraw, P., Huebner, K., Croce, C. M., and Pierotti, M. A. Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities. Cancer Res., 57: 5207-5212, 1997.
46. Mao, L., Lee, J. S., Kurie, J. M., Fan, Y. H., Lippman, S. M., Lee, J. J., Ro, J. Y., Broxson, A., Yu, R., Morice, R. C., Kemp, B. L., Khuri, F. R., Walsh, G. L., Hittelman, W. N., and Hong, W. K. Clonal genetic alterations in the lungs of current and former smokers. J. Natl. Cancer Inst., 89: 857-862, 1997.
47. Sozzi, G., Sard, L., De Gregorio, L., Marchetti, A., Musso, K., Buttitta, F., Tornielli, S., Pellegrini, S., Veronese, M. L., Manenti, G., Incarbone, M., Chella, A., Angeletti, C. A., Pastorino, U., Huebner, K., Bevilaqua, G., Pilotti, S., Croce, C. M., and Pierotti, M. A. Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res., 57: 2121-2123, 1997.
48. Mao, L., Lee, J. S., Fan, Y. H., Ro, J. Y., Batsakis, J. G., Lippman, S., Hittelman, W., and Hong, W. K. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat. Med., 2: 682-685, 1996.
49. Sundaresan, V., Ganly, P., Hasleton, P., Rudd, R., Sinha, G., Bleehen, N. M., and Rabbitts, P. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumors, are detectable in preinvasive lesions of the bronchus. Oncogene, 7: 1989-1997, 1992.